Cargando…
Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities
The American College of Rheumatology guidelines provides a strong recommendation for the use of biologic disease-modifying antirheumatic drugs (bDMARDs) when conventional rheumatoid arthritis treatments fail to meet treatment targets. Although bDMARDs are an effective and important treatment compone...
Autores principales: | Peterman, Nicholas J, Vashi, Aksal, Govan, Devan, Bhatia, Amrit, Vashi, Tejal, Kaptur, Brad, Yeo, Eunhae G, Gizinski, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339343/ https://www.ncbi.nlm.nih.gov/pubmed/35923666 http://dx.doi.org/10.7759/cureus.26448 |
Ejemplares similares
-
Demographic and Geospatial Analysis of Buprenorphine and Methadone Prescription Rates
por: Peterman, Nicholas J, et al.
Publicado: (2022) -
Analysis of Rural Disparities in Ultrasound Access
por: Peterman, Nicholas J, et al.
Publicado: (2022) -
Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis
por: Paul, Sanjoy K, et al.
Publicado: (2021) -
The future of COVID-19: A vaccine review
por: Vashi, Aksal P., et al.
Publicado: (2021) -
Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study
por: Robinson, Yohan, et al.
Publicado: (2017)